In melanoma, the BRAF gene is the most commonly mutated, with the BRAF subtype detected in approximately 50% (40% to 60%) of individuals, activating the mitogen-activated protein (MAP) kinase pathway [43,44]. The gene discussed is BRAF; the disease is melanoma.